Skip directly to content

Physician Education: Rheumatology

Collaborating on New Vasculitis Research

UPMC is one of eight academic centers funded to conduct vasculitis treatment studies scheduled to begin in 2013.  The centers involved in the studies will collectively assemble the data, providing researchers with enough information to draw accurate conclusions about the treatment and management of vasculitis.

Using Plasmapheresis to Treat Vasculitis

Researchers at UPMC are participating in a trial to evaluate the efficacy of plasmapherisis as a therapeutic option for vasculitis.

The Challenge of Diagnosing and Treating Lupus

Systemic Lupus Erythematosus - or SLE - is a disease that affects millions worldwide and is sometimes difficult to diagnose. And even once a diagnosis is made, it's equally difficult to treat. Marc Levesque, MD, PhD, of UPMC discusses new medications that are being studied to modify the body's immune response and to treat lupus. When diagnosed early and treated with the right combination of drugs, the progression of SLE can usually be slowed, improving patients' quality of life.

Using Treat to Target in Rheumatoid Arthritis

It's a common practice for hypertension and diabetes but a relatively new idea in the treatment of rheumatoid arthritis. Using a treat to target approach, doctors use quantifiable measures such as joint counts, blood work, and health assessment questionnaires to assess the progression of a disease. Based on these scores, a patient's disease is deemed active, low active or in remission and a treatment plan will be developed accordingly.